Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global Bio-chem Technology Group Co's revenue for the
six
months ended in Dec. 2025 was $140.4 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $291.5 Mil.
Global Bio-chem Technology Group Co's Revenue per Share for the
six
months ended in Dec. 2025 was $4.18.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $12.66.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Global Bio-chem Technology Group Co Revenue Related Terms
Global Bio-chem Technology Group Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Global Bio-chem Technology Group Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Bio-chem Technology Group Co Revenue vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Global Bio-chem Technology Group Co's Revenue distribution charts can be found below:
* The bar in red indicates where Global Bio-chem Technology Group Co's Revenue falls into.
Global Bio-chem Technology Group Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $291.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Bio-chem Technology Group Co (GBCMY) has a Revenue of $291.5 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Global Bio-chem Technology Group Co and its competitors.
Is Global Bio-chem Technology Group Co's Revenue too high?
Global Bio-chem Technology Group Co's current Revenue is $291.5 Mil. Overall, Global Bio-chem Technology Group Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Global Bio-chem Technology Group Co's Revenue compare to KHC and GIS?
Global Bio-chem Technology Group Co's Revenue of $291.5 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Consumer Packaged Goods company?
A good Revenue depends on the Consumer Packaged Goods industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Global Bio-chem Technology Group Co and its competitors. Global Bio-chem Technology Group Co's current Revenue is $291.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Bio-chem Technology Group Co stock overvalued right now?
Global Bio-chem Technology Group Co (GBCMY) has a current Revenue of $291.5 Mil. The current Revenue is $291.5 Mil. Global Bio-chem Technology Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Global Bio-chem Technology Group Co (GBCMY), the current Revenue is $291.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Global Bio-chem Technology Group Co Ltd is engaged in the manufacture and sale of corn refined products and amino acids. The upstream corn refinery serves as a feedstock which breaks down corn kernels into corn starch, gluten meal, fibre and corn oil; and corn starch is further refined through a series of biochemical and/or chemical processes into a wide range of high value-added downstream products. Its segments include the upstream products segment; and the amino acids segment engages in the manufacture and sale of corn based biochemical products, including lysine and threonine. It derives the majority of the revenue from the amino acids segment. Geographically, it operates in The PRC, and Asia, the Americas and other regions.
33GF Score
Get the complete analysis for GBCMY
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCMY has been successfully added to your 
